Oct. 1 at 2:43 AM
$XLO If Xilio were valued the way the market is pricing CTMX and HOWL, it would already be a
$3 -
$5 stock.
Just compare their pipeline and clinical progress, partnerships and validation, platform strength and potential. So why is the market still valuing Xilio at microcap levels?
A few weeks ago, the market cap was
$30 million. Even now around
$43 million, its still nowhere close to where it should be.
